Exagen Inc.
NASDAQ:XGN
Overview | Financials
Company Name | Exagen Inc. |
Symbol | XGN |
Currency | USD |
Price | 2.79 |
Market Cap | 48,508,056 |
Dividend Yield | 0% |
52-week-range | 1.3 - 3.71 |
Industry | Diagnostics & Research |
Sector | Healthcare |
CEO | Mr. John Aballi |
Website | https://www.exagen.com |
An error occurred while fetching data.
About Exagen Inc.
Exagen Inc. develops and commercializes various testing products based on its cell-bound complement activation products technology under the AVISE brand in the United States. It enables rheumatologists to care for patients through the diagnosis, prognosis, and monitoring of autoimmune and autoimmune-related diseases, including systemic lupus erythematosus (SLE) and rheumatoid arthritis
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD